Open AccessPB2261: LINEZOLID AS A SAFE ANTIMICROBIAL AGENT IN THROMBOCYTOPENIC PATIENTS UNDERGOING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES
Author(s) -
Angotzi F.,
Cellini A.,
Marinello S.,
Cattelan A.,
Trentin L.,
Gurrieri C.,
Lessi F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851872.90312.73
Subject(s) - medicine , cohort , neutropenia , febrile neutropenia , linezolid , chemotherapy , surgery , multiple myeloma , induction chemotherapy , adverse effect , retrospective cohort study , pneumonia , gastroenterology , vancomycin , staphylococcus aureus , biology , bacteria , genetics